<?xml version="1.0" encoding="UTF-8"?><CAS version="2"><uima.cas.Sofa _indexed="0" _id="1" sofaNum="1" sofaID="_InitialView" mimeType="text" sofaString="P07624581A0312 All subjects were submitted to ECG and arterial blood pressure determination and were assayed for TSH, thyroid hormone, PRL, glucose, creatinine, nitrogen, glutamine transaminase, cholesterol and triglycerides plasma levels before therapy (T0), after 30 treatment days (T30) and after a 15 days washout (T45)."/><uima.tcas.DocumentAnnotation _indexed="1" _id="8" _ref_sofa="1" begin="0" end="324" language="x-unspecified"/><edu.cmu.tanl.type.gene _indexed="1" _id="13" _ref_sofa="1" begin="83" end="85" Gene="TSH"/><edu.cmu.tanl.type.gene _indexed="1" _id="18" _ref_sofa="1" begin="87" end="100" Gene="thyroid hormone"/><edu.cmu.tanl.type.gene _indexed="1" _id="23" _ref_sofa="1" begin="102" end="104" Gene="PRL"/><edu.cmu.tanl.type.gene _indexed="1" _id="28" _ref_sofa="1" begin="134" end="154" Gene="glutamine transaminase"/></CAS>